Australia faces increased PBS costs, potential medicine shortages, reduced export revenues, and delayed access to new drugs due to the MFN executive order. Tariffs could exacerbate these effects, straining trade relations and sector stability. The uncertainty until HHS sets targets (June 11, 2025) and assesses progress (November 12, 2025) means Australia must prepare for volatility, possibly through enhanced domestic production or trade advocacy, while navigating a likely prolonged adjustment period.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.42 |
Change
-0.120(0.96%) |
Mkt cap ! $1.553B | |||
| Open | High | Low | Value | Volume |
| $12.61 | $12.68 | $12.34 | $2.489M | 198.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 501 | $12.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.43 | 73 | 4 |
View Market Depth
| Last trade - 12.01pm 25/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |